ENGOT-ov-6/TRINOVA-2: Randomised, double-blind, phase 3 study of pegylated liposomal doxorubicin plus trebananib or placebo in women with recurrent partially platinum-sensitive or resistant ovarian…
Overview of attention for article published in European Journal of Cancer (1965), December 2016
Altmetric Attention Score: 13
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (88th percentile)
-
High Attention Score compared to outputs of the same age and source (83rd percentile)
Readers on
- mendeley
- 88 Mendeley
- citeulike
- 1 CiteULike